COMP <GO>
UTMD vs PDEX // EV/EBITDA & P/E VALUATION
Utah Medical Products Inc. (NASDAQ) VS. Pro-Dex Inc. (NASDAQ) • 15-METRIC TALLY: UTMD 7
— PDEX 3
▲ EV/EBITDA & P/E VALUATION LEADER: UTMD
LAST: $66.80 (-2.96%) • MKT CAP: $212.7M
valuation
10.8x
LAST: $61.60 (-2.52%) • MKT CAP: $199.2M
valuation
16.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UTMD VS. PDEX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UTMD | PDEX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.10% | 29.30% | +27.80 | UTMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.90% | 23.20% | +3.70 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.8x | 16.5x | -5.70 | UTMD | /valuation <GO> |
| Free Cash Flow Yield | 6.73% | -1.47% | +8.20 | UTMD | /fcf-yield <GO> |
| Operating Margin | 29.60% | 16.10% | +13.50 | UTMD | /operating-margins <GO> |
| Net Profit Margin | — | 13.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.80% | 23.70% | -29.50 | PDEX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.87% | 0.00% | +1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 9.08 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | PDEX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.1 | 38.5 | -8.40 | PDEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $212.7M | $199.2M | $13.5M | UTMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UTMD REV | PDEX REV | UTMD GROSS % | PDEX GROSS % | UTMD FCF | PDEX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.5M | $66.6M | 57.1% | 29.3% | $14.3M | -$2.9M |
| FY 2024 | $40.9M | $53.8M | 59.0% | 27.0% | $14.6M | $6.2M |
| FY 2023 | $50.2M | $46.1M | — | — | $22.3M | $5.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UTMD // BETA —
PDEX // BETA —